1,490 followers
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
RT @JACCJournals: #ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. F…
#ESCCongress presentation assesses why #SGLT2 inhibitor #empagliflozin prevents heart failure development in diabetics. Full study published in #JACCBTS shows it may increase the cardiac energy pool: https://t.co/M0zXTlP1aW @UAlberta @StMikesHospital https